(UBU7) UBS (Irl) - MSCI World - Ratings and Ratios
Stocks, Equity, Global, Large-Cap, Blend
Description: UBU7 UBS (Irl) - MSCI World
The UBS (Irl) ETF plc - MSCI World UCITS ETF (USD) A-dis EUR is a Global Large-Cap Blend Equity ETF listed on the XETRA exchange with the ticker symbol UBU7. It tracks the Morningstar Global TME NR USD index, providing diversified exposure to large-cap equities worldwide.
From a performance perspective, the ETF has shown stability with its current price hovering around its moving averages. To further analyze its performance, key metrics such as the Sharpe Ratio, Tracking Error, and Information Ratio can be considered. A high Sharpe Ratio would indicate that the ETF has generated excess returns relative to its risk, while a low Tracking Error would suggest that it closely follows its benchmark index.
In terms of its investment characteristics, the ETFs Assets Under Management (AUM) stand at 318.76M EUR, indicating a moderate level of investor interest. To gauge its liquidity and trading activity, metrics such as Average Daily Trading Volume and Bid-Ask Spread can be examined. A high Average Daily Trading Volume and a narrow Bid-Ask Spread would suggest that the ETF is liquid and can be traded efficiently.
To evaluate the ETFs investment strategy, its holdings and sector allocation can be analyzed. The MSCI World index is known for its diversified exposure to developed markets, with a significant allocation to the US market. The ETFs sector allocation is likely to be weighted towards technology, healthcare, and financials, given the indexs composition. Investors can assess the ETFs alignment with their investment objectives by examining its holdings and sector allocation.
UBU7 ETF Overview
| Market Cap in USD | 1,337m |
| Category | Global Large-Cap Blend Equity |
| TER | 0.10% |
| IPO / Inception | 2012-04-11 |
UBU7 ETF Ratings
| Growth Rating | 58.0 |
| Fundamental | - |
| Dividend Rating | 58.5 |
| Rel. Strength | -5.60 |
| Analysts | - |
| Fair Price Momentum | 104.86 EUR |
| Fair Price DCF | - |
UBU7 Dividends
| Dividend Yield 12m | 1.46% |
| Yield on Cost 5y | 2.72% |
| Annual Growth 5y | 8.21% |
| Payout Consistency | 95.1% |
| Payout Ratio | % |
UBU7 Growth Ratios
| Growth Correlation 3m | 88% |
| Growth Correlation 12m | 15.7% |
| Growth Correlation 5y | 89.8% |
| CAGR 5y | 13.53% |
| CAGR/Max DD 5y | 0.62 |
| Sharpe Ratio 12m | 0.92 |
| Alpha | -3.18 |
| Beta | 0.757 |
| Volatility | 14.58% |
| Current Volume | 1.8k |
| Average Volume 20d | 4.8k |
| Stop Loss | 86.5 (-3.1%) |
| Signal | -2.15 |
What is the price of UBU7 shares?
Over the past week, the price has changed by +1.30%, over one month by +2.82%, over three months by +4.70% and over the past year by +11.87%.
Is UBS (Irl) - MSCI World a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UBU7 is around 104.86 EUR . This means that UBU7 is currently undervalued and has a potential upside of +17.5% (Margin of Safety).
Is UBU7 a buy, sell or hold?
What are the forecasts/targets for the UBU7 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 117.2 | 31.4% |
UBU7 Fundamental Data Overview
Market Cap EUR = 1.14b (1.14b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 EUR
Beta = 0.0
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.14b EUR (1.14b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 1.14b)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.14b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(1.14b)/V(0.0) * Re(8.80%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
Discount Rate = 8.80% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)